DNA X delays quarterly filing over preferred stock accounting

By Public Technologies
  • DNA X delayed its Form 10-Q for the three months ended September 30, 2026, as preferred stock accounting prolonged its financial close.
  • The accounting review concerns related-party preferred stock issuances, including whether to classify the stock as mezzanine equity or permanent equity.
  • The company expects to file within five calendar days of the prescribed due date.
  • Net loss from continuing operations is expected at approximately $1.3 million, versus approximately $2.2 million in the corresponding 2025 period.
  • The narrower loss reflects $500,000 in prior-year interest expense on promissory notes repaid in January 2026 and $400,000 in prior-year divestiture-related legal fees.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052817), on November 17, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk